Davies Simon J
Department of Nephrology, University Hospital of North Staffordshire, Stoke-on-Trent, Staffordshire, United Kingdom.
Kidney Int. 2004 Dec;66(6):2437-45. doi: 10.1111/j.1523-1755.2004.66021.x.
Time on treatment is associated with a greater risk of impaired ultrafiltration (UF) in peritoneal dialysis (PD) patients. In addition to increasing solute transport, a potentially treatable cause of impaired ultrafiltration, cross-sectional studies suggest that there is also reduced osmotic conductance of the membrane. If this were the case then it would be expected that the UF capacity for a given rate of solute transport would change with time. The purpose of this analysis was to establish how solute transport and UF capacity change relative to one another with time on therapy.
Membrane function, using a standard peritoneal equilibration test, was measured at least annually in a well-characterized, single-center observational cohort of PD patients between 1990 and 2003. Demography included age, gender, original cause of renal failure, body surface area (BSA), validated comorbidity score, residual urine volume and urea clearances, peritoneal urea clearances, and plasma albumin.
Data from 574 new PD patients were available for analysis. Independent demographic factors associated with higher solute transport at baseline were male gender and higher residual urine volume. Throughout time on therapy there was a negative relationship between solute transport and UF capacity and a significant increase and decrease in these parameters, respectively. During the first 12 months of treatment, the increase in solute transport was not associated with the expected fall in UF capacity, a phenomenon that was not explained by informative censoring, but was associated with an increased, albeit weak, correlation with BSA. In contrast, later in treatment there was a disproportionate fall in UF capacity, more accelerated in patients developing UF failure. Early exposure to higher intraperitoneal glucose concentrations, in the context of more comorbidity and relative lack of residual renal function, was associated with more rapid deterioration in membrane function.
Despite a causal link between solute transport and UF capacity of the membrane, due to the effect of the former on the osmotic gradient, there is evidence of their longitudinal dissociation. This implies a change in the structure-function relationship with time on treatment that can, to some extent, be predicted from clinical factors present within the first year of treatment. Dialysis-induced membrane injury must involve at least two processes, for example, increased vascular surface area contact with dialysate combined with changes in hydraulic conductance due to scarring of the vessels and interstitium.
治疗时间与腹膜透析(PD)患者超滤功能受损的风险增加相关。除了增加溶质转运外,超滤功能受损的一个潜在可治疗原因是横断面研究表明膜的渗透传导性也降低。如果是这种情况,那么预计在给定溶质转运速率下的超滤能力会随时间变化。本分析的目的是确定溶质转运和超滤能力在治疗过程中如何随时间相互变化。
在1990年至2003年期间,对一个特征明确的单中心观察性队列中的PD患者,至少每年使用标准腹膜平衡试验测量一次膜功能。人口统计学信息包括年龄、性别、肾衰竭的原发病因、体表面积(BSA)、验证的合并症评分、残余尿量和尿素清除率、腹膜尿素清除率以及血浆白蛋白。
有574例新的PD患者的数据可供分析。与基线时较高溶质转运相关的独立人口统计学因素是男性性别和较高的残余尿量。在整个治疗过程中,溶质转运与超滤能力之间存在负相关,且这些参数分别有显著增加和下降。在治疗的前12个月,溶质转运的增加与超滤能力预期的下降无关,这一现象无法通过信息性删失来解释,但与BSA的相关性增加(尽管较弱)有关。相比之下,在治疗后期,超滤能力下降不成比例,在发生超滤功能衰竭的患者中下降更为加速。在合并症较多且残余肾功能相对缺乏的情况下,早期暴露于较高的腹腔内葡萄糖浓度与膜功能更快恶化相关。
尽管溶质转运与膜的超滤能力之间存在因果联系,由于前者对渗透梯度的影响,但有证据表明它们在纵向存在解离。这意味着治疗过程中结构 - 功能关系会随时间变化,在一定程度上可以根据治疗第一年存在的临床因素进行预测。透析引起的膜损伤必须至少涉及两个过程,例如,血管表面积与透析液接触增加,以及由于血管和间质瘢痕形成导致的水力传导性变化。